Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Gilead Sciences (GILD) Ascends While Market Falls: Some Facts to Note
06:55pm, Thursday, 03'rd Apr 2025
Gilead Sciences (GILD) reachead $112.39 at the closing of the latest trading day, reflecting a +0.45% change compared to its last close.
Gilead Sciences (GILD) Ascends But Remains Behind Market: Some Facts to Note
07:05pm, Wednesday, 02'nd Apr 2025
In the most recent trading session, Gilead Sciences (GILD) closed at $111.88, indicating a +0.54% shift from the previous trading day.
Final Trades: Gilead Sciences, Amazon, Alphabet and KLA Corp.
01:52pm, Wednesday, 02'nd Apr 2025
The Investment Committee give you their top stocks to watch for the second half.
Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term
10:46am, Wednesday, 02'nd Apr 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
10:06am, Wednesday, 02'nd Apr 2025
Recently, Zacks.com users have been paying close attention to Gilead (GILD). This makes it worthwhile to examine what the stock has in store.
2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating
07:49pm, Tuesday, 01'st Apr 2025
When Wall Street analysts decide to come out of their caves and boost a certain stock, retail investors should pay attention to the motives behind the decision as it can signal a shift in sentiment to
2 Healthcare Stocks to Watch as JPMorgan Boosts Gilead Rating
07:48pm, Tuesday, 01'st Apr 2025
When Wall Street analysts decide to come out of their caves and boost a certain stock, retail investors should pay attention to the motives behind the decision as it can signal a shift in sentiment to
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
02:01pm, Tuesday, 01'st Apr 2025
Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are 'underappreciated.'
GILD or AMGN: Which Is the Better Value Stock Right Now?
12:40pm, Tuesday, 01'st Apr 2025
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Gilead Sciences (GILD) and Amgen (AMGN). But which of these two companies is the best op
Are Medical Stocks Lagging Gilead Sciences (GILD) This Year?
10:45am, Wednesday, 26'th Mar 2025
Here is how Gilead Sciences (GILD) and AngioDynamics (ANGO) have performed compared to their sector so far this year.
Gilead Sciences (GILD) Stock Drops Despite Market Gains: Important Facts to Note
06:55pm, Monday, 24'th Mar 2025
The latest trading day saw Gilead Sciences (GILD) settling at $106.67, representing a -0.38% change from its previous close.
Gilead: Expansion Of Livdelzi For PBC Continues With European Marketing Approval
12:36pm, Sunday, 23'rd Mar 2025
Gilead Sciences shows strong growth in its HIV and oncology franchises, with BIKTARVY and TRODELVY driving significant revenue increases in 2024. LIVDELZI's conditional approvals in the U.S. and Europ
Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights
07:05pm, Thursday, 20'th Mar 2025
In the closing of the recent trading day, Gilead Sciences (GILD) stood at $105.87, denoting a -1.53% change from the preceding trading day.
GILD Stock Down on Report of Cut in HIV Prevention Spending
04:01pm, Thursday, 20'th Mar 2025
Gilead Sciences takes a hit after a Wall Street Journal reports state that the Trump administration is looking to slash funding for HIV prevention in the country.
Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet
10:30am, Thursday, 20'th Mar 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
